Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788551 | SCV000927703 | uncertain significance | not provided | 2018-05-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002068546 | SCV002404417 | benign | 3MC syndrome 1 | 2024-02-26 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV002068546 | SCV003920180 | uncertain significance | 3MC syndrome 1 | 2021-12-08 | criteria provided, single submitter | clinical testing | MASP1 NM_139125.3 exon 11 p.Arg503Cys (c.1507C>T): This variant has not been reported in the literature but is present in 0.6% (69/10366) of Ashkenazi Jewish alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/3-186954152-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:636655). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Laboratory of Diagnostic Genome Analysis, |
RCV000788551 | SCV001797682 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000788551 | SCV001974911 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003965584 | SCV004778323 | likely benign | MASP1-related disorder | 2022-05-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |